Herpes Statistics 2026: Demographics and Trends

U.S. HSV Prevalence (Ages 14-49)

Source: CDC/NCHS NHANES 2015-2016 (seroprevalence; rounding for display)

📹 Video: Herpes — Causes, Symptoms & Pathology

▶ Opens on YouTube

U.S. Prevalence (What the numbers look like in America)

The most commonly cited U.S. numbers come from NHANES (National Health and Nutrition Examination Survey), which includes HSV antibody testing. Because it is a survey, estimates come with uncertainty ranges and can vary slightly by cycle, but NHANES remains one of the best public sources for U.S. seroprevalence.

For ages 14–49 in 2015–2016:

• HSV-1: 47.8%
• HSV-2: 11.9%

That means HSV-2 affects roughly 1 in 8 people in that age band. So the often-quoted “1 in 6” is a broad public estimate used in some older messaging, but the CDC’s NHANES data shows 11.9% for HSV-2 in ages 14–49 for that cycle.

Important caveat: antibody (serology) tells you whether someone has been infected in the past, not whether they currently have symptoms. It also does not perfectly distinguish oral from genital HSV-1 infection.

Age Demographics: HSV Increases With Age

One of the most consistent findings: HSV prevalence rises with age, not because something “switches on,” but because infection risk accumulates over time and antibodies persist.

CDC NHANES analyses repeatedly show that HSV-1 and HSV-2 seroprevalence generally increases across older age bands in the 14–49 group. The exact shape of the curve can vary by sex and subgroup, but the overall pattern is stable.

Key insight: HSV-1 is very common worldwide (WHO estimates ~64% under 50 globally). In some higher-income countries, childhood HSV-1 acquisition has declined, which can shift the age distribution and may increase the proportion of first HSV-1 infections occurring later (including via oral sex). That does not change the global reality that HSV-1 remains highly prevalent.

Gender Differences: Women Have Higher HSV-2 Rates

This is one of the most consistent findings in surveillance: women have higher HSV-2 seroprevalence than men in many settings, including the U.S.

CDC analysis of NHANES 2015–2016 reported age-adjusted HSV-2 prevalence:

• Females: 15.9%
• Males: 8.2%

Why the difference? Male-to-female transmission is often more efficient biologically (mucosal exposure). Social and network factors also matter, including patterns of age-discordant partnering and differences in testing and healthcare access. None of this implies anything about behavior or “fault.” It reflects how the virus spreads.

Important Trends in 2026

1) HSV-1 is increasingly a cause of genital herpes

WHO emphasizes that HSV-1 can be transmitted to the genital area through oral sex, contributing to genital HSV-1 infections alongside traditional HSV-2 genital infections. In practice, the share of new genital herpes caused by HSV-1 is often higher among younger people in some countries, although this varies by region and background HSV-1 exposure.

2) Many infections are asymptomatic or unrecognized

WHO notes most HSV infections are asymptomatic or unrecognized. People may have mild symptoms they do not identify as herpes, or no noticeable outbreaks at all. This helps explain why prevalence is high and why stigma can be out of proportion to day-to-day health impact for many people. At the same time, asymptomatic shedding can still transmit the virus, which is why prevention tools (condoms, dental dams, suppressive antivirals for HSV-2 in some cases, and disclosure) matter.

3) “Genital herpes” is not the same as “HSV-2”

A common messaging mistake is treating those as identical.

• HSV-2 is a major driver of genital herpes globally
• But genital herpes also includes genital HSV-1, and WHO’s estimate of ~846 million genital herpes infections includes both types

Practical implication: When you see statistics, check whether the author is talking about HSV-2 specifically (often measured by blood tests) or genital herpes overall (which combines HSV-1 and HSV-2 and may be estimated differently).

Key Takeaways (The Numbers in Plain English)

• If you’re human and have been alive a while, HSV is part of the landscape
• Globally: ~64% under 50 have HSV-1; ~13% ages 15–49 have HSV-2 (WHO modeled estimates)
• U.S. (NHANES 2015–2016, ages 14–49): ~48% HSV-1, ~12% HSV-2
• HSV prevalence increases with age, and HSV-2 is more common in women than men in U.S. serosurveys

The Bigger Picture

The most surprising herpes statistic is how unsurprising it actually is. The numbers do not support panic. They support normalization, accurate risk communication, and better conversations.

HSV is not a tragedy that happens to “someone else.” It is a common virus affecting hundreds of millions (and for HSV-1, billions) of people worldwide, most of whom manage it without crisis. Still, some people have frequent outbreaks, complications, or significant anxiety. Those experiences are real, and they deserve good medical care and support.

Want to know where you might fall in these statistics? Try our HSV risk calculator above to explore your personal risk profile based on age, exposure, and other factors.